Nebivolol Potentiates the Efficacy of PDE5 Inhibitors to Relax Corpus Cavernosum and Penile Arteries from Diabetic Patients by Enhancing the NO/cGMP Pathway-Reference-Cited by-同舟云学术

Nebivolol Potentiates the Efficacy of PDE5 Inhibitors to Relax Corpus Cavernosum and Penile Arteries from Diabetic Patients by Enhancing the NO/cGMP Pathway

Published:2014-05 Issue:5 Volume:11 Page:1182-1192
ISSN:1743-6095
Container-title:The Journal of Sexual Medicine
language:en
Short-container-title:The Journal of Sexual Medicine

Author:

Martínez‐Salamanca Juan I.,La Fuente José M.,Cardoso José,Fernández Argentina,Cuevas Pedro,Wright Harold M.,Angulo Javier

Publisher

Elsevier BV

Subject

Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health

Reference48 articles.

1. Trabecular smooth muscle modulates the capacitor function of the penis: Studies on a rabbit model;Sáenz de Tejada;Am J Physiol,1991

2. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle;Ignarro;Biochem Biophys Res Commun,1990

3. A nitric oxide‐like factor mediates nonadrenergic‐noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle;Kim;J Clin Invest,1991

4. Anatomy, physiology, and pathophysiology of erectile dysfunction;Gratzke;J Sex Med,2010

5. Erectile dysfunction in diabetes mellitus;Malavige;J Sex Med,2009

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PKC Inhibition Improves Human Penile Vascular Function and the NO/cGMP Pathway in Diabetic Erectile Dysfunction: The Role of NADPH Oxidase;International Journal of Molecular Sciences;2024-03-07

2. Simvastatin attenuates diabetes mellitus erectile dysfunction in rats by miR-9-5p-regulated PDCD4;Acta Biochimica Polonica;2023-11-06

3. A Review on Epigenetic Toxicological Mechanisms of Sildenafil and Its Metabolites, the Emerging Pollutants;Reviews of Environmental Contamination and Toxicology;2023-10-17

4. Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie’s disease;The Journal of Sexual Medicine;2023-04-20

5. New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session;Current Drug Metabolism;2023-02